Exactech Q1 Revenue Up 6% to $69.5 Million On 21% Extremities Growth Post author:Sam Post published:April 25, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Gilead Announces Second Quarter 2017 Financial Results July 26, 2017 Blue Earth Diagnostics Receives Positive Opinion For Axumin (Fluciclovine (18F)) For PET Imaging Of Recurrent Prostate Cancer March 23, 2017 Cambridge Cognition Ltd Release: Company Awarded U.S. Regulatory Clearance For CANTAB Mobile January 24, 2017
Blue Earth Diagnostics Receives Positive Opinion For Axumin (Fluciclovine (18F)) For PET Imaging Of Recurrent Prostate Cancer March 23, 2017
Cambridge Cognition Ltd Release: Company Awarded U.S. Regulatory Clearance For CANTAB Mobile January 24, 2017